Prior candidate genetic studies and genome-wide association studies have been central in identifying genetic factors that contribute to the development of cognitive dysfunction in PD, in particular the significant role of Apolipoprotein E Epsilon 4 (APOE ε4) in modulating risk of cognitive decline9–11. The gene discussed is APOE; the disease is Parkinson disease.